Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy
NCT ID: NCT04664543
Last Updated: 2021-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
100 participants
INTERVENTIONAL
2019-12-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the early days of colonoscopy, a liquid diet for 48 hours was mainly recommended, although some centers indicated a low-residue diet or even the commercially available NASA astronaut diet. Later, the indication for a liquid diet was consolidated until finally numerous studies were published in favor of a low-residue diet, managing to increase tolerance and the quality of the preparation . A limitation of the preparation studies must be borne in mind that the colon cleansing rating scales were not introduced until 1999 when the Aronchick scale was published.
Although there is solid evidence in favor of a low-residue diet versus a liquid diet, the investigators do not have evidence on how many days of a low-residue diet should be recommended, and this is reflected in the ESGE (European Society of Gastrointestinal Endoscopy) and ASGE (American Society of Gastrointestinal Endoscopy) guidelines . A randomized clinical trial comparing 3 days versus 1 day of a low residue diet has recently been published . There were no statistically significant differences in the rate of adequate preparations (82.7% vs. 85.6% OR 1.2 95% IC 0.72 to 2.15). However, this study has limited statistical power and a design that allows a non-inferiority analysis has not been followed. In relation to this, our research group is finalizing a non-inferiority clinical trial in whose intermediate analysis, with 421 participants, the non-inferiority of 1 day of diet is fulfilled (rate of poor preparation in 1 day 0.95% vs. 4.74% in 3 days; d + 5%, difference -3.78% IC -6.88% to -1.12%) (38).
It is likely, taking into account the available evidence and its evolution, that diet plays a secondary role in preparation. Although no studies designed to directly assess this have been conducted, the research group has indirect data.
Walter et al, under the hypothesis that the impact of the fractional preparation and the new preparations on the preparation diminished the importance of the diet, conducted a non-inferiority clinical trial between 2012 and 2013 in which they randomized the patients to follow a diet liquid versus low residue for one day and fractional preparation with Moviprep (39). They established a non-inferiority margin of -13.5%. Their results show a rate of good preparation (Boston\> 5) in 68/72 (94.4%) in a liquid diet compared to 60/68 (88.2%) in a low-residue diet (p = 0.04) with a difference of -5.08% demonstrating non-inferiority of the low residue diet.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy
NCT03763266
Written Recommendation to Improve Adherence in Poor Bowel Preparation
NCT05709145
The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy
NCT02540031
3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability
NCT02955901
Impact of Digital Tools on the Quality of Bowel Preparation for Colonoscopy
NCT05734079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3 days of low residue diet
Currently participants in the colorectal cancer screening program follow a 3 days low residue diet before colonoscopy. This is the active comparator arm of this study.
Three days low residue diet
To follow the three days before colonoscopy a diet with low content in fiber or residues.
Free diet
Participants assigned to this arm are NOT instructed to follow any kind of restriction in the diet before colonoscopy.
Free diet
To follow the regular dietary habits with no restriction nor modification.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Free diet
To follow the regular dietary habits with no restriction nor modification.
Three days low residue diet
To follow the three days before colonoscopy a diet with low content in fiber or residues.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants in the Program for the Early Detection of Colorectal Cancer with a positive result in the test for detecting occult blood in feces
* That they accept a colonoscopy and that they agree to participate in the study.
Exclusion Criteria
* Severe renal insufficiency (\<30 ml / min).
* Known hypersensitivity or allergy to polyethylene glycol, ascorbic acid or sulfate.
* Known glucose-6-phosphate dehydrogenase deficiency.
* Known phenylketonuria.
* Known dyselectrolytemia: hyper / hyponatremia, hyperphosphatemia, hypermagnesemia, hyper / hypokalemia, hypocalcemia.
* Gastric emptying disorders: Known gastroparesis.
* Known hypoalbuminemia less than 3.4 g / dl.
* Crohn's disease or known ulcerative colitis.
* Participants with difficult-to-control hypertension (SBP\> 170mmHg or TAD\> 100mmHg) or NYHA grade III or IV heart failure.
* Ascites of any etiology
* People with cognitive impairment or mental illness that makes it difficult to adhere to instructions.
* People who do not understand Catalan or Spanish.
* Factors of poor preparation: liver cirrhosis, diabetes mellitus, treatment with tricyclic antidepressants, opioids or neuroleptics, limited mobility, chronic constipation, history of colon or intestinal resection (appendectomy is not an exclusion criterion), poor preparation in previous colonoscopy Parkinson's disease, multiple sclerosis.
50 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari de Terrassa
OTHER
Hospital Mutua de Terrassa
OTHER
Parc Taulí Hospital Universitari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salvador Machlab
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Martínez, PhD
Role: STUDY_DIRECTOR
Hospital Universitari Parc Taulí
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari Parc Taulí
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Machlab Mashlab S, Martinez-Bauer E, Lopez P, Pujals MDM, Fernandez-Banares F, Selva A, Calvet X, Campo R. Unrestricted vs three-day low-residue diet for colonoscopy preparation. Results of a feasibility randomized trial. Rev Esp Enferm Dig. 2025 Jun;117(6):349-350. doi: 10.17235/reed.2024.10417/2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019307
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.